Aiolos Seeks To Block Mass. Suit Over $1B GSK Deal
Aiolos Bio Inc. and two of its founders have asked the Delaware Chancery Court to stop a former Tier1 Bio Inc. stockholder from pursuing a Massachusetts lawsuit over Tier1's 2023 dissolution...To view the full article, register now.
Already a subscriber? Click here to view full article